ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of Early Allograft Dysfunction on Graft and Patient Outcomes After Liver Transplantation.

Z. Guo, D. Zheng, X. He, G. Chen.

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Meeting: 2017 American Transplant Congress

Abstract number: A257

Keywords: Graft function

Session Information

Session Name: Poster Session A: Organ Preservation and Reperfusion

Session Type: Poster Session

Date: Saturday, April 29, 2017

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall D1

Objective: To evaluate the short-term and long-term impact of early allograft dysfunction (EAD) on graft and patient outcomes after liver transplantation.

Background: EAD is one early complication of liver transplantation. It is not clarified to what extent and how long EAD affects the patient and graft outcomes after liver transplantation.

Methods: A systematic literature search for comparative studies concerning EAD versus non EAD for post-transplant outcomes was conducted in PubMed, Web of Science, Embase and Google Scholar database.

Results: Twenty-two studies involving 10048 subjects were eligible. EAD had a strong effect on the 6-month graft failure (OR=5.20, 95% CI=4.01-6.73) and recipient mortality (OR=5.76, 95% CI=4.28-7.75). There was moderate association between EAD and outcomes at 1 year (graft failure: OR=2.86, 95% CI=2.43-3.36; mortality: OR=2.54, 95% CI=2.13-3.04) and 5 years (graft failure: OR=1.98, 95% CI=1.67-2.35; mortality: OR=1.74, 95% CI=1.45-2.08) EAD was associated with longer stay in both hospital (mean difference=3.81, 95% CI=2.40-5.22) and intensive care unit (mean difference=3.14, 95% CI=2.09-4.19). Patients with EAD had higher risks of post-operative complications, including primary non-function (OR=9.72, 95% CI=5.86-16.13), retransplantation (OR=2.59, 95% CI=1.89-3.55), infection (OR=1.49, 95% CI=1.11-2.00), acute steroid-resistant rejection (OR=1.59, 95% CI=1.11-2.29) and renal insufficiency which requires hemodialysis (OR=2.29, 95% CI=1.80-2.93).

Conclusions: EAD has long-lasting deleterious impact on post-transplant graft and recipient outcomes after liver transplantation. Efforts should be made to prevent and treat EAD to improve graft and patient survival.

CITATION INFORMATION: Guo Z, Zheng D, He X, Chen G. Impact of Early Allograft Dysfunction on Graft and Patient Outcomes After Liver Transplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Guo Z, Zheng D, He X, Chen G. Impact of Early Allograft Dysfunction on Graft and Patient Outcomes After Liver Transplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-early-allograft-dysfunction-on-graft-and-patient-outcomes-after-liver-transplantation/. Accessed June 8, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences